Delivering Personalized Medicine: Focus on Pharmacogenomics, Medication Optimization and Collaborative Care Models to Enhance Patient Outcomes & Topics in Allergy and Immunology

Delivering Personalized Medicine: Focus on Pharmacogenomics, Medication Optimization and Collaborative Care Models to Enhance Patient Outcomes & Topics in Allergy and Immunology is organized by Continuing Education, Inc. and will be held from Sep 05 - 12, 2020 at Royal Caribbean's Rhapsody of the Seas, Venice, Veneto, Italy.

Target Audience:
Physicians, Physician Assistants, Nurses, Nurse Practitioners, Pharmacists

Accreditation:
• 14 AMA PRA Category 1 Credits™
• 14 ACPE Credits
• 14.0 Contact Hours
• 8 Hours of Pharmacology for NPs

Program Purpose:
This program will focus on the following and allow participants to:
• Recognize the evolving role pharmacogenomics is playing in the delivery of personalized medicine.
• Describe common sources for medication-related miscommunications and how poor medication adherence can impact the clinical and economic outcomes for patient, providers, and stakeholders.
• Discuss the rationale for collaborative models of care that deliver enhanced clinical, patient, and economic outcomes.

From Pharmacogenomics to Personalized Medicine:
After attending the following session individuals should be able to:
• Identify new personal health care technologies and the impact they may have on patient outcomes.
• Distinguish benefits and limitations of genetic testing and use in managing medications in specific patients.
• Evaluate various gene-drug (biomarker-drug) pairs with pharmacogenomic applications.
• Critique the various resources (e.g., CPIC, PharmGKB, FDA) for pharmacogenomics drug-gene pairs.
• Understand the difference between preemptive and reactive testing of drug-gene pairs.
• Discuss the economic cost or impact considerations related to pharmacogenomic testing.
• Understand practical approaches to counseling/patient education related to pharmacogenomics.

Optimizing Medication Adherence and Outcomes:
After attending the following session individuals should be able to:
• Create strategies to promote medications adherence among all healthcare providers.
• Describe the impact of poor adherence on clinical and economic outcomes for patient and stakeholders.
• Associate the necessary points within the medication use system in which technologies can be employed to reduce medical errors and enhance patient outcomes

Comprehensive Medication Management Services:
After attending the following session individuals should be able to:
• Outline the value of leveraging the prescription benefit to reduce downstream healthcare costs and outcomes.
• Critique the rationale for collaborative models of care that deliver enhanced clinical, patient and economic outcomes that involves pharmaceutical benefits.
• Recognize the importance of aligning incentives in a ?pay for performance? model that includes all providers.

Topics in Allergy and Immunology:
• Urticaria
• Angioedema
• Atopic Dermatitis
• Food Allergy
• Drug Allergy
• Sinusitis
• Indoor Allergies